Kholoud Al Busaidi: Cold Agglutination and Its Impact on CBC and Blood Grouping Results
Kholoud Al Busaidi, Medical Laboratory Intern at Ministry of Health Oman, shared a post on LinkedIn:
“Had a patient with visible RBC clumping in the EDTA sample. That raised the possibility of cold agglutination, potentially related to cold-reactive IgM antibodies.
The first CBC results were clearly questionable. An extremely high MCHC combined with a low RBC count and HCT was a major red flag.
Then the blood group came back as AB positive, while the patient’s previous record showed O positive. That discrepancy needed to be investigated.
So I warmed the EDTA sample at 37 degree C for 30 minutes and repeated the CBC. The results came back much more consistent.
For the blood grouping, the red cells were washed with normal saline, and the ABO Rh typing was repeated.
The result was O positive, matching the patient’s previous record.
Now, this doesn’t mean we’re making a clinical diagnosis of cold agglutination. From the laboratory side, the findings were suggestive of possible cold agglutination and, more importantly, showed potential analytical interference.
Cold agglutination can interfere with automated CBC parameters, particularly RBC count, HCT, MCV, MCH, and MCHC.
So when the numbers don’t make sense, you don’t force them to make sense.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian